The myelodysplastic syndrome (MDS) patients diagnosed between 1986 and 1992 were evaluated. There were 40 patients, 21 of them were female and 19 of them were male. Ages were between 16 and 71 (mean 44.00 ± 17.46). About half of them (19/40) were younger than 40 years old which is much younger than the previously reported cases. Twenty-six of them had refractory anemia (RA), 4 had refractory anemia with ringed sideroblast (RARS), 4 had refractory anemia with excess blasts (RAEB) and 6 had refractory anemia with excess blasts transformation (RAEB/t). Granulocytic sarcoma preceded the development of blastic transformation (BT) in one case, tuberculosis in one case and membranous glomerulonephritis accompanied MDS in one case. Clinical course ...
Myelodysplastic syndromes affect an older age group with a median age at onset in the eighth decade ...
Myelodysplastic syndromes (MDS) are a collection of pathologi-cally and cytogenetically distinct bon...
1. Classification Peripheral blood cytopenias in combination with a hy-percellular bone marrow assoc...
We report on our experience relating to 62 patients with myelodysplastic syndrome (MDS) aged less th...
Myelodysplastic syndromes (MDS) mainly occur in elderly individuals in Western countries. However, M...
Fifty three (45 males, 8 females) patients with primary meylodysplastic syndrome were seen between J...
Twenty patients with Myelodysplastic Syndrome (MDS) were diagnosed in University Hospital, Kuala Lum...
Myelodysplastic syndrome (MDS) represent very heterogenous group of clonal stem cell bone marrow dis...
Abstract Less than 10% of MDS patients are younger than 50 years. A series of 91 younger patients (m...
A retrospective analysis was done on 113 patients (median age 73 years) with myelodysplastic syndrom...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Myelodysplastic syndrome (MDS) constitutes 1-16% percent of haematological malignancies in childhood...
Myelodysplastic syndromes (MDS) are fairly common hematological disorder of elderly. They are a grou...
peer reviewedThe myelodysplastic syndromes (MDS) are a heterogeneous group of disorders characterize...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Myelodysplastic syndromes affect an older age group with a median age at onset in the eighth decade ...
Myelodysplastic syndromes (MDS) are a collection of pathologi-cally and cytogenetically distinct bon...
1. Classification Peripheral blood cytopenias in combination with a hy-percellular bone marrow assoc...
We report on our experience relating to 62 patients with myelodysplastic syndrome (MDS) aged less th...
Myelodysplastic syndromes (MDS) mainly occur in elderly individuals in Western countries. However, M...
Fifty three (45 males, 8 females) patients with primary meylodysplastic syndrome were seen between J...
Twenty patients with Myelodysplastic Syndrome (MDS) were diagnosed in University Hospital, Kuala Lum...
Myelodysplastic syndrome (MDS) represent very heterogenous group of clonal stem cell bone marrow dis...
Abstract Less than 10% of MDS patients are younger than 50 years. A series of 91 younger patients (m...
A retrospective analysis was done on 113 patients (median age 73 years) with myelodysplastic syndrom...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Myelodysplastic syndrome (MDS) constitutes 1-16% percent of haematological malignancies in childhood...
Myelodysplastic syndromes (MDS) are fairly common hematological disorder of elderly. They are a grou...
peer reviewedThe myelodysplastic syndromes (MDS) are a heterogeneous group of disorders characterize...
Myelodysplastic syndromes (MDS) are clonal disorders of the multipotent hematopoietic stem cell char...
Myelodysplastic syndromes affect an older age group with a median age at onset in the eighth decade ...
Myelodysplastic syndromes (MDS) are a collection of pathologi-cally and cytogenetically distinct bon...
1. Classification Peripheral blood cytopenias in combination with a hy-percellular bone marrow assoc...